Related Experiment Video
Updated: May 24, 2026

08:20
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
[Post-menopausal ovarian hyperthecosis].
A-L Castell1, S Hieronimus, A Chevallier
1Service d'endocrinologie, gynécologie et reproduction, hôpital l'Archet, CHU de Nice, 151 route de Saint-Antoine-Ginestière, Nice, France.
Gynecologie, Obstetrique & Fertilite
|February 17, 2012
Summary
Ovarian hyperthecosis is a rare cause of post-menopausal hyperandrogenia. Surgical removal of ovaries confirmed the condition and stopped excess androgen production.
Area of Science:
- Endocrinology
- Gynecology
- Reproductive Medicine
Background:
- Ovarian hyperthecosis is an infrequent cause of post-menopausal hyperandrogenia.
- Its pathophysiology is poorly understood, but insulin resistance and elevated luteinizing hormone (LH) may play a role, similar to polycystic ovarian syndrome.
Observation:
- Four post-menopausal patients presented with hyperandrogenia.
- High testosterone levels, enlarged ovaries without focal lesions, and metabolic syndrome suggested ovarian hyperthecosis.
- Bilateral annexectomy was performed for diagnosis and treatment.
Findings:
- Histological examination confirmed ovarian hyperthecosis, characterized by specific luteinized stromal cells.
- The surgical intervention led to the complete cessation of inappropriate androgen secretion.
Implications:
- This case series highlights the importance of considering ovarian hyperthecosis in post-menopausal women with hyperandrogenia.
- Surgical management can effectively resolve androgen excess in these patients.
- Further research into the pathophysiology of ovarian hyperthecosis is warranted.
Related Concept Videos
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Oogenesis
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...